Efficacy and Safety Oral Contraceptive Study
NCT00185484
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1113
Enrollment
INDUSTRY
Sponsor class
Conditions
Contraception
Interventions
DRUG:
YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
Sponsor
Bayer